Cargando…
B cell therapy and the use of RNA-based COVID-19 vaccines
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938733/ https://www.ncbi.nlm.nih.gov/pubmed/33883063 http://dx.doi.org/10.1016/j.msard.2021.102887 |
| _version_ | 1783661644066324480 |
|---|---|
| author | Vishnevetsky, Anastasia Hawkes, Chris Lechner-Scott, Jeannette Giovannoni, Gavin Levy, Michael Pohl, Daniela |
| author_facet | Vishnevetsky, Anastasia Hawkes, Chris Lechner-Scott, Jeannette Giovannoni, Gavin Levy, Michael Pohl, Daniela |
| author_sort | Vishnevetsky, Anastasia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7938733 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79387332021-03-09 B cell therapy and the use of RNA-based COVID-19 vaccines Vishnevetsky, Anastasia Hawkes, Chris Lechner-Scott, Jeannette Giovannoni, Gavin Levy, Michael Pohl, Daniela Mult Scler Relat Disord Editors Welcome Elsevier B.V. 2021-04 2021-03-08 /pmc/articles/PMC7938733/ /pubmed/33883063 http://dx.doi.org/10.1016/j.msard.2021.102887 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Editors Welcome Vishnevetsky, Anastasia Hawkes, Chris Lechner-Scott, Jeannette Giovannoni, Gavin Levy, Michael Pohl, Daniela B cell therapy and the use of RNA-based COVID-19 vaccines |
| title | B cell therapy and the use of RNA-based COVID-19 vaccines |
| title_full | B cell therapy and the use of RNA-based COVID-19 vaccines |
| title_fullStr | B cell therapy and the use of RNA-based COVID-19 vaccines |
| title_full_unstemmed | B cell therapy and the use of RNA-based COVID-19 vaccines |
| title_short | B cell therapy and the use of RNA-based COVID-19 vaccines |
| title_sort | b cell therapy and the use of rna-based covid-19 vaccines |
| topic | Editors Welcome |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938733/ https://www.ncbi.nlm.nih.gov/pubmed/33883063 http://dx.doi.org/10.1016/j.msard.2021.102887 |
| work_keys_str_mv | AT vishnevetskyanastasia bcelltherapyandtheuseofrnabasedcovid19vaccines AT hawkeschris bcelltherapyandtheuseofrnabasedcovid19vaccines AT lechnerscottjeannette bcelltherapyandtheuseofrnabasedcovid19vaccines AT giovannonigavin bcelltherapyandtheuseofrnabasedcovid19vaccines AT levymichael bcelltherapyandtheuseofrnabasedcovid19vaccines AT pohldaniela bcelltherapyandtheuseofrnabasedcovid19vaccines |